MONOCLONAL ANTIBODIES TO ANGIOTENSIN-(1-12), COMPOSITIONS INCLUDING THE SAME, AND METHODS OF USE THEREOF

ANTIBODY MOLECULES

EPHA2 antibodies

ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF

Use of an Anti-P-selectin Antibody

Immunomodulation and anti-tumor-related nanobody and nucleic acid encoding sequence thereof, and uses of the same

Anti-immune-checkpoint nanobody and nucleic acid encoding sequence thereof, and uses of the same

Single Domain Antibodies to Programmed Cell Death (PD-1)

Antibody targeting CD22 and CD79B

USE OF HIGH-AFFINITY, LIGAND-BLOCKING, HUMANIZED ANTI-T-CELL IMMUNOGLOBULIN DOMAIN AND MUCIN DOMAIN-3 (TIM-3) IGG4 ANTIBODY FOR THE TREATMENT OF MYELOFIBROSIS

ANTI-VSIG4 ANTIBODY OR ANTIGEN BINDING FRAGMENT AND USES THEREOF

COMPOSITIONS INCLUDING IGG FC MUTATIONS AND USES THEREOF

Anti-TIGIT antibodies

MODIFIED DOSING OF VEGF INHIBITORS FOR OPHTHALMIC USE

NEUTRALIZING ANTIBODIES THAT BIND TO THE ZIKA VIRUS DOMAIN III ENVELOPE REGION

Methods of Purifying Masked Antibodies

ANTIBODY-INTERLEUKIN FUSION PROTEIN AND METHODS OF USE

METHODS AND COMPOSITIONS FOR GENETICALLY MODIFYING LYMPHOCYTES TO EXPRESS POLYPEPTIDES COMPRISING THE INTRACELLULAR DOMAIN OF CD79A AND CD79B

IMMUNE MICROBUBBLE COMPLEX, AND USE THEREOF

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

Inhibition of Vascular Matrix Metalloproteinase-9 to Treat Ischemic Injury

Serpinf2-Binding Molecules and Method of Use Thereof

METHODS AND COMPOSITIONS FOR MODIFYING MACROPHAGE POLARIZATION INTO PRO-INFLAMMATORY CELLS TO TREAT CANCER

ANTI-CD22 ANTIBODIES AND USES THEREOF

E-CADHERIN ACTIVATING ANTIBODIES AND USES THEREOF

CD47 ANTIGEN-BINDING MOLECULES

COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES

METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR

Treatment of Cancers Lacking EGFR- Activating Mutations

ANTI-B7-H3 ANTIBODY AND METHODS OF USE THEREOF

ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS OF USE THEREOF

Antibodies binding PD-L1 and uses thereof

ANTI-PD-1 ANTIBODY IN COMBINATION WITH AN ANTI-CD30 ANTIBODY IN CANCER TREATMENT

Bispecific Antibody Targeting CD3 and CD20 and Use Thereof

USE OF ANTI-FCRN ANTIBODIES IN THE TREATMENT OF PEMPHIGHUS AND PEMPHIGOID DISEASES

Bispecific Chimeric Antigen Receptor

Anti-TMEFF1 antibodies and antibody drug conjugates

Safe and Effective Method of Treating Psoriatic Arthritis with Anti-IL23 Specific Antibody

ANTI-HUMAN P40 PROTEIN DOMAIN ANTIBODY AND USE THEREOF

Methods for Treatment of Subjects with Psoriatic Arthritis

METHODS FOR REDUCING DRUG-INDUCED LIVER INJURY

Novel Molecules for Therapy and Diagnosis

ANTIBODIES AND METHODS FOR TREATMENT OF VIRAL INFECTIONS

Antibodies to Andes hantavirus, and methods for using same

TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

Immunoconjugate

METHODS FOR TREATMENT USING PHTHALOCYANINE DYE-TARGETING MOLECULE CONJUGATES

COMBINED USE OF ARTIFICIAL ADJUVANT VECTOR CELLS AND AN IMMUNOSTIMULANT

TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA

ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS

METHOD OF IMPROVING EFFICACY OF MELANOMA TREATMENT

PREDICTING EXTRAINTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE

CHEMICALLY CONTROLLED MONOCLONAL ANTIBODY TARGET ENGAGEMENT

ANTI-CANCER PEPTIDE

ADAMTS binding immunoglobulins

Biopharmacuetical Compositions and Related Methods

ANTI-CD40 ANTIBODIES AND USES THEREOF

ANTI-AVBETA8 ANTIBODIES AND COMPOSITIONS AND USES THEREOF

Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody

Anti-PACAP antibodies and uses thereof

Method of Treating Psoriatic Arthritis Patients with Inadequate Response to TNF Therapy with Anti-IL23 Specific Antibody

Use of beta-catenin as a biomarker for treating cancers using anti-Dkk-1 antibody

ANTIBODIES SPECIFICALLY RECOGNIZING PSEUDOMONAS PCRV AND USES THEREOF

HUMAN MONOCLONAL ANTIBODIES TO ENTEROVIRUS D68

LILRB1-based chimeric antigen receptor

T-cell modulatory multimeric polypeptides and methods of use thereof

FLT3 ligand fusion proteins and methods of use

USE OF IMMUNOCYTOKINE COMPRISING INTERFERON-BETA OR VARIANT THEREOF FOR TREATING HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 POSITIVE CANCER

ANTI-EGFR ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Muscle targeting complexes and uses thereof for treating dystrophinopathies

Photosensitizing antibody-fluorophore conjugates

Anti-podocalyxin antibodies and methods of using the same

Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates

Small molecule trail gene induction by normal and tumor cells as an anticancer therapy

CREATINE FOR IMMUNOTHERAPY

METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS

IDENTIFICATION OF PATIENTS IN NEED OF PD-L1 INHIBITOR COTHERAPY

Immunomodulating transgenic plants and related methods

Compositions and methods to regulate Renalase in the treatment of cancer

Method and Compositions for Inducing Differentiation of Myeloid Derived Suppressor Cell to Treat Cancer and Infectious Diseases

TARGETED CHIMERIC PROTEINS AND USES THEREOF

Anti-SIRPa antibodies and their therapeutic applications

High concentration antibody-containing liquid formulation

BISPECIFIC ANTIBODY CAR CELL IMMUNOTHERAPY

Compositions and Methods for the Treatment of Cancer (Anti-ICOS Antibody Dosing)

BISPECIFIC ANTIBODY

ANTI-CD33 ANTIBODIES AND METHODS OF USE THEREOF

TREM2 ANTIBODIES AND USES THEREOF

TREATMENT OF PD-L1-POSITIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY

FORMULATION COMPRISING ANTI-PD-1/HER2 BISPECIFIC ANTIBODY, METHOD FOR PREPARING SAME AND USE THEREOF

Antibodies directed against GDF-15

Fc VARIANTS WITH ALTERED BINDING TO FcRn

TETRANECTIN-TARGETING MONOCLONAL ANTIBODIES TO FIGHT AGAINST LETHAL SEPSIS AND OTHER PATHOLOGIES

Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof

Dual cytokine fusion proteins comprising IL-10

Dosage regimes for the administration of an anti-CD19 ADC

METHODS OF TREATMENT USING A LEPTIN RECEPTOR AGONIST ANTIBODY

ANTIBODIES TO CANDIDA AND USES THEREOF

Subcutaneously administered anti-IL-6 receptor antibody

Anti-C5 antibody combinations and uses thereof

ANTI-CD300C MONOCLONAL ANTIBODY AND BIOMARKER THEREOF FOR PREVENTING OR TREATING CANCER

ANTI-CD38 ANTIBODIES AND METHODS OF USE

Use of Approved Anti-CD38 Antibody Drug Product to Treat Light Chain Amyloidosis

ANTI-CD38 ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF, AND PHARMACEUTICAL USE

Method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases

PROTEASE-ACTIVATED T CELL BISPECIFIC MOLECULES

Checkpoint blockade and microsatellite instability

Markers of acute myeloid leukemia stem cells

Antifibrotic activity of CD47 blockade in the liver

Bispecific Epitope Binding Protein Comprising Anti-4-1BB Antibody and a PD-1 Protein or Fragments Thereof and Use Thereof

Covalent Diabodies and Uses Thereof

BINDING MOLECULE SPECIFIC FOR LRIG-1 PROTEIN AND USE THEREOF

BINDING MOLECULE SPECIFIC TO LRIG-1 PROTEIN, AND USE THEREOF

IL-38-SPECIFIC ANTIBODIES

Anti-myostatin antibodies and methods of use

METHODS AND COMPOSITIONS FOR PDGF-CC INHIBITION

ANTIBODIES THAT BIND TO PATHOLOGICAL TAU SPECIES AND USES THEREOF

DOSAGE AND ADMINISTRATION REGIMEN FOR THE TREATMENT OR PREVENTION OF C5-RELATED DISEASES BY THE USE OF THE ANTI-C5 ANTIBODY CROVALIMAB

DOSAGE AND ADMINISTRATION REGIMEN FOR THE TREATMENT OR PREVENTION OF C5-RELATED DISEASES BY THE USE OF THE ANTI-C5 ANTIBODY CROVALIMAB

BINDING AGENTS AND USES THEREOF

Antibody compositions for disrupting biofilms

Anti-CHIKV antibodies and uses thereof

THERAPEUTIC PROTEIN FORMULATIONS COMPRISING ANTIBODIES AND USES THEREOF

ANTI-PRE-S1 HBV ANTIBODIES

RELAXIN ANALOGS AND METHODS OF USING THE SAME

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

HSP Fusion Protein with Anti-Chemorepellant Agent for Treatment of Cancer

Compositions, formulations and methods for treating ocular diseases

Constrained conditionally activated binding proteins

Constrained conditionally activated binding proteins

HORSE IL-31 INDUCED PRURITUS MODEL

SELF-ASSEMBLED VACCINES AND COMBINATION THERAPIES FOR TREATING CANCER

Use of a VEGF antagonist to treat angiogenic eye disorders

METHODS FOR PRODUCING POLYPEPTIDES BY REGULATING POLYPEPTIDE ASSOCIATION

Gene-regulating compositions and methods for improved immunotherapy

Human Anti-SOD1 Antibodies

BINDING MEMBERS

EPCAM BINDING PROTEINS AND METHODS OF USE

ANTI-TM4SF1 ANTIBODIES AND METHODS OF USING SAME

Miniaturized antibody of anti-glucocorticoid-induced tumor necrosis factor receptor (GITR), and polymer and use thereof

COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE

COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE

Inhibition of cytokine-induced SH2 protein in NK cells

Methods and Compositions for Determining Susceptibility to Treatment with Checkpoint Inhibitors

ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR TARGETING TGF-ß SIGNALING IN CD4+ HELPER T CELLS FOR CANCER IMMUNOTHERAPY

ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF

Methods for Manipulating Phagocytosis Mediated by CD47

TRISPECIFIC ANTIBODY TARGETING BCMA, GPRC5D, AND CD3

USE OF IL-1ß BINDING ANTIBODIES FOR TREATING NEUROINFLAMMATORY DISORDERS

METHOD FOR TREATING AUTOIMMUNE DISEASE BY IL-17 ANTAGONIST

Compositions and methods for treatment of diseases involving CXCL1 function

BLOCKADE OF RGMb FOR TREATING INFLAMMATORY BOWEL DISEASE AND COLITIS

METHODS OF USING ANTIBODIES RECOGNIZING TAU

Antibodies to human complement factor C2B and methods of use

Doppel-targeting antibodies

ANTI-MESOTHELIN ANTIBODIES

ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF

MULTIMERIC SARS-COV-2 BINDING MOLECULES AND USES THEREOF

Methods for the treatment of neurodegeneration

LONG-LASTING GLP1 ANALOGUE DRUG FOR TYPE-2 DIABETES

Dual cytokine fusion proteins comprising IL-10

PROTEINS COMPRISING BINDING REGIONS, SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS, AND CARBOXY-TERMINAL, ENDOPLASMIC RETICULUM LOCALIZATION SIGNAL MOTIFS

ANTI-CD40 ANTIBODY DRUG CONJUGATES

Unit dose of a composition for treating cancer

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY

TUMOR IMMUNOTHERAPY USING SINDBIS VIRAL VECTORS AND AGONIST MONOCLONAL ANTIBODIES

THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B

Antibodies or antibody-fragments thereof targeting alphaviruses, and compositions and methods comprising same

FUSION PROTEIN OF ETA ANTIBODY AND TGF-BETA TRAP AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA

METHODS OF TREATING AND DIAGNOSING INFLAMMATORY BOWEL DISEASE

TETRAVALENT BISPECIFIC ANTIBODY, PREPARATION METHOD THEREFOR, AND USE THEREOF

Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders

Anti-NME antibody and method of treating cancer or cancer metastasis

COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS

ANTIBODIES BINDING TO GPRC5D

FLT3-specific chimeric antigen receptors and methods using same

Multiple-Variable Dosage Regimen for the Treatment of Cancers with High Expression of EGFR

BISPECIFIC ANTIBODIES SPECIFIC FOR PD1 AND TIM3

ADMINISTRATION OF A PD-1 INHIBITOR FOR FOR TREATING SKIN CANCER

Checkpoint blockade and microsatellite instability

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

FCRN ANTIBODIES AND METHODS OF USE THEREOF

CD33 ANTIBODIES AND METHODS OF USING THE SAME TO TREAT CANCER

Heavy-chain antibodies (VHHs) against claudin 18A2 and use thereof

VACCINE COMPOSITION COMPRISING A MUTANT OF HUMAN INTERLEUKIN-15

ANTI-IL-27 ANTIBODIES AND USES THEREOF

Neutralizing Antibody for Tooth Regeneration Treatment Targeting USAG-1 Molecule

Binding moieties for biofilm remediation

Antibodies against microorganisms and uses thereof

A METHOD OF TREATING HBV INFECTION BY USING ANTI-PRE-S1 HBV ANTIBODIES

Anti-LAG3 antibodies and antigen-binding fragments

METHOD FOR PRECONDITIONING A SUBJECT WHO IS ABOUT TO RECEIVE A T-CELL THERAPY

COMBINATION THERAPY FOR CANCER

COMBINATION OF INTEGRIN-TARGETING KNOTTIN-FC FUSION AND ANTI-CD47 ANTIBODY FOR THE TREATMENT OF CANCER

MARROW INFILTRATING LYMPHOCYTES (MILs) EXPRESSING CHIMERIC ANTIGEN RECEPTORS (CAR), METHOD OF MANUFACTURING SAME, AND METHOD OF USING IN THERAPY

MICROLUMENAL TARGETING OF CANCER CELLS

COMPOSITIONS AND METHODS FOR TREATING CEREBRAL VASOSPASM

BINDING MOLECULES FOR BCMA AND CD3

Antibodies for Botulinum Neurotoxins

Multi-specific binding proteins for cancer treatment

MAGEA10 SPECIFIC T CELL RECEPTORS AND THEIR USE

Antibodies having specificity for CD38 and uses thereof

BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF

IL-6Ralpha/IL-8R BISPECIFIC BINDING AGENTS FOR INHIBITING CANCER CELL MIGRATION

Anti-B7-H4 antibodies and immunoconjugates

ANTI-PD-L1 COMBINATIONS FOR TREATING TUMORS

Caninized Antibodies Against Canine CTLA-4

ANTI-CTLA4 ANTIBODY PRODRUGGABLE (PROBODY) AT A CDR POSITION

Compositions of programmed death receptor 1 (PD-1) antibodies and methods of obtaining the compositions thereof

Use of anti-PD-1 antibody in combination with famitinib in preparation of drug for treating tumors

FUSIONS OF MUTANT INTERLEUKIN-2 POLYPEPTIDES WITH ANTIGEN BINDING MOLECULES FOR MODULATING IMMUNE CELL FUNCTION

CD137- and DLL3-targeting multispecific antigen-binding molecules

EXTRACELLULAR VESICLES TARGETING T CELLS AND USES THEREOF

Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody

CD200R AGONIST ANTIBODIES AND USES THEREOF

ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE

Low dose antibody-based methods for treating hematologic malignancies

SEMAPHORIN 3A ANTIBODIES AND USES THEREOF

THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING CANCER IN COMBINATION WITH ANALOGS OF INTERLEUKIN PROTEINS

ANTI-CD33 ANTIBODIES AND METHODS OF USE THEREOF

Binding molecule specific for Lrig-1 protein and use thereof

AGENTS THAT INTERFERE WITH THYMIC STROMAL LYMPHOPOIETIN (TSLP)-RECEPTOR SIGNALING

Antibodies to amyloid beta

COMPOSITION AND METHODS TO TREAT ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE

TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIESHEREOF

METHODS AND COMPOSITIONS RELATING TO ANTI-NUCLEOLIN RECOMBINANT IMMUNOAGENTS

FUSION PROTEIN COMPRISING ANTI-MESOTHELIN ANTIBODY, ANTI-CD3 ANTIBODY OR ANTI-EGFR ANTIBODY, BISPECIFIC OR TRISPECIFIC ANTIBODY COMPRISING SAME, AND USES THEREOF

Compositions and methods for treating and preventing infections

Anti-spike glycoprotein antibodies and the therapeutic use thereof

ANTI-HEPATITIS B VIRUS ANTIBODIES AND USE THEREOF

Cytotoxic particles for targeting P2X7 receptor

T-CELL DEPLETING THERAPIES

METHODS OF TREATING AUTOIMMUNE AND ALLOIMMUNE DISORDERS

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES

Methods Of Treatment Of Keloid Using An Anti-VEGF Agent

ANTI-PD-1 ANTIBODIES AND METHODS OF USE THEREOF

Combination therapy for treating cancer with an antibody and intravenous administration of a recombinant MVA

COMBINATION THERAPY WITH CD13-TARGETED CHIMERIC PROTEINS OR CHIMERIC PROTEIN COMPLEXES

PDL1 POSITIVE NK CELL CANCER TREATMENT

ANTI-DLL3 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

CCR4 TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FOR TREATMENT OF CCR4 POSITIVE MALIGNANCIES

Regimen for suppressing organ rejection

Recombinant Polyclonal Proteins and Methods of Use Thereof

RECOMBINANT FAP BINDING PROTEINS AND THEIR USE

Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria

NOVEL IMMUNOCONJUGATES

GLYCAN-BASED ANTIBODY-DRUG CONJUGATES

ANTIBODY POLYPEPTIDES AND USES THEREOF

Anti-CEACAM5 monoclonal antibody and preparation method thereof and use thereof

COMPOSITIONS AND METHODS FOR REGULATING ERYTHROPOIESIS

B-CELL ACTIVATING CD73 ANTIBODIES

4-1BB AND OX40 BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS, ANTIBODIES AGAINST 4-1BB, ANTIBODIES AGAINST OX40

CD3 antibody and pharmaceutical use thereof

Anti-IL1RAP antibody

PROVASOPRESSIN ANTAGONISTS AND USES THEREOF

METHODS AND MATERIALS FOR TARGETED EXPANSION OF REGULATORY T CELLS

Anti-abeta antibodies

Humanized anti-A β monoclonal antibody and application thereof

HUMANIZED ANTI-A[BETA] MONOCLONAL ANTIBODY AND APPLICATION THEREOF

ANTIBODIES AND FC FUSION PROTEIN MODIFICATIONS WITH ENHANCED PERSISTENCE OR PHARMACOKINETIC STABILITY IN VIVO AND METHODS OF USE THEREOF

C3D CELLULAR AND ACELLULAR VACCINES FOR THE PREVENTION AND TREATMENT OF CANCER

FORMULATION OF HUMAN ANTIBODIES FOR TREATING TNF-ALPHA ASSOCIATED DISORDERS

COMBINATION THERAPIES

IMMUNE CELLS HAVING CO-EXPRESSED SHRNAS AND LOGIC GATE SYSTEMS

HUMANIZED ANTIBODIES TO MUCIN-16 AND METHODS OF USE THEREOF

ANTI-CEACAM5 MONOCLONAL ANTIBODY, PREPARATION METHOD THEREOF AND USE THEREOF

ANTIBODY WITH ENHANCED BINDING AFFINITY FOR ENDOTHELIN RECEPTOR TYPE A

CAR-T CELLS TARGETING IL-1RAP AND THEIR USE IN ACUTE MYELOID LEUKEMIA (AML)

MONOCLONAL ANTIBODY-CYTOKINE FUSION PROTEIN DIMER AND APPLICATION THEREOF

CLDN18.2 ANTIBODY AND USE THEREOF

ANTI-NOTCH3 ANTIBODY

Method of treating dupuytren's disease using a pre-filled syringe

Method of using antibody molecules to detect a proliferation-inducing ligand (APRIL)

Humanized tetra-specific octavalent antibody against clostridium difficile toxin A and B

NOVEL ANTI-HEPATITIS B VIRUS ANTIBODY AND USES THEREOF

Soluble Universal ADCC-Enhancing Synthetic Fusion Gene and Peptide Technology and Its Use Thereof

COMBINED THERAPIES OF ACTIVATABLE IMMUNE CHECKPOINT INHIBITORS AND CONJUGATED ACTIVATABLE ANTIBODIES

Antibody Compositions and Methods of Use Thereof

High concentration immunoglobulin composition for pharmaceutical application

Automated heart valve manufacturing devices and methods

Recombinant intravenous immunoglobulin (RIVIG) compositions and methods for their production and use

TOXOPLASMA PLATFORM FOR TREATING CANCER

METHODS FOR TREATING LYMPHOMA

Systems and Methods for Sequencing T Cell Receptors and Uses Thereof

METHODS FOR DNA-DEPENDING TARGETING OF A CELL PERMEANT ANTIBODY

COMPLEMENT INHIBITION FOR IMPROVED NERVE REGENERATION

ANTI-ADAM8 ANTIBODIES AND USES OF THE SAME

MONOCLONAL ANTIBODY AND A METHOD OF USE FOR THE TREATMENT OF LUPUS

ANTI-HVEM ANTIBODIES AND USE THEREOF

Bispecific antigen binding molecules comprising anti-FAP clone 212

ANTIBODIES THAT BIND HUMAN CD27 AND USES THEREOF

Anti-TEM1 antibodies and antigen-binding portions thereof

Methods and compositions for modulating CAR-T activity

CONTROLLING OF IMMUNE ACTIVATION BY SOLUBLE CLEVER-1

NOVEL MODULATORS